Inventor · disambiguated record
Lorena Lerner
Also filed as: LERNER LORENA
12 granted patents·20 pending applications·41 citations·filing 2006–2025
88Inventor score
Files withAVEO PHARMACEUTICALS INC16ONCORUS INC8ELEVATEBIO TECH INC3SCHOLAR ROCK INC2VIROGIN BIOTECH CANADA LTD2
Top patents by PatentIndex Score
32 records- 0192US9175076B2Anti-GDF15 antibodiesAVEO PHARMACEUTICALS INC·Filed 2013·Granted Nov 3, 2015·16 cites·11 claims
- 0291US11725047B2Anti-GDF-15 antibodiesAVEO PHARMACEUTICALS INC·Filed 2020·Granted Aug 15, 2023·2 cites·20 claims
- 0391US9725505B2Methods of treatment using anti-GDF15 antibodiesAVEO PHARMACEUTICALS INC·Filed 2015·Granted Aug 8, 2017·9 cites·36 claims
- 0490US12208126B2Oncolytic viral vectors and uses thereofVIROGIN BIOTECH CANADA LTD·Filed 2023·Granted Jan 28, 2025·1 cites·23 claims
- 0586US12258391B2Anti-GDF-15 antibodiesAVEO PHARMACEUTICALS INC·Filed 2023·Granted Mar 25, 2025·0 cites·18 claims
- 0686US10597444B2Anti-GDF15 antibodiesAVEO PHARMACEUTICALS INC·Filed 2017·Granted Mar 24, 2020·4 cites·9 claims
- 0781US8603478B2Anti-RON antibodiesWHALEN KERRY·Filed 2011·Granted Dec 10, 2013·6 cites·14 claims
- 0880US2024366518A1Compounds, compositions, and methods of using thereofELEVATEBIO TECH INC·Filed 2024·Application pending·0 cites
- 0976US2025277019A1Anti-gdf-15 antibodiesAVEO PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1074US2023295285A1Methods of reversing cachexia and prolonging survival comprising administering a gdf15 modulator and an anti-cancer agentAVEO PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1172US11612625B2Oncolytic viral vectors and uses thereofONCORUS INC·Filed 2018·Granted Mar 28, 2023·1 cites·26 claims
- 1272US2022403015A1Treatment of congestive heart failure and other cardiac dysfunction using a gdf15 modulatorAVEO PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1371US2024173267A1Compounds, compositions, and methods of using thereofONCORUS INC·Filed 2022·Application pending·0 cites
- 1466US2019292253A1Methods of reversing cachexia and prolonging survival comprising administering a gdf15 modulator and an anti-cancer agentAVEO PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1564US7556796B2Directed complementationAVEO PHARMACEUTICALS INC·Filed 2006·Granted Jul 7, 2009·2 cites·12 claims
- 1661US2024390439A1Compositions and methods of seneca valley virus (svv) related cancer therapyELEVATEBIO TECH INC·Filed 2024·Application pending·0 cites
- 1760US2025304669A1Rgmc-selective inhibitors and use thereofSCHOLAR ROCK INC·Filed 2025·Application pending·0 cites
- 1859US8829164B2Anti-ron antibodiesAVEO PHARMACEUTICALS INC·Filed 2013·Granted Sep 9, 2014·0 cites·11 claims
- 1958US11897948B2Treatment of chronic kidney disease and other renal dysfunction using a GDF15 modulatorAVEO PHARMACEUTICALS INC·Filed 2018·Granted Feb 13, 2024·0 cites·27 claims
- 2058US2025049867A1Engineered oncolytic herpesvirusesVIROGIN BIOTECH CANADA LTD·Filed 2022·Application pending·0 cites
- 2157US2019292251A1Treatment of congestive heart failure and other cardiac dysfunction using a gdf15 modulatorAVEO PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2256US12297262B2RGMC-selective inhibitors and use thereofSCHOLAR ROCK INC·Filed 2019·Granted May 13, 2025·0 cites·35 claims
- 2354US2024115636A1Encapsulated rna polynucleotides and methods of useELEVATEBIO TECH INC·Filed 2022·Application pending·0 cites
- 2453US2017306008A1Methods of reversing cachexia and prolonging survival comprising administering a gdf15 modulator and an anti-cancer agentAVEO PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2551US2022380735A1Dual viruses and dual oncolytic viruses and methods of treatmentONCORUS INC·Filed 2020·Application pending·0 cites
- 2650US2022117902A1Encapsulated rna polynucleotides and methods of useONCORUS INC·Filed 2020·Application pending·0 cites
- 2749US2023416308A1Encapsulated rna replicons and methods of useONCORUS INC·Filed 2021·Application pending·0 cites
- 2848US2021403950A1Encapsulated polynucleotides and methods of useONCORUS INC·Filed 2019·Application pending·0 cites
- 2948US2023227577A1Anti-dll3 antibodies and methods of useONCORUS INC·Filed 2021·Application pending·0 cites
- 3047US2017137505A1Treatment of congestive heart failure and other cardiac dysfunction using a gdf15 modulatorAVEO PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3142US2020224220A1Encapsulated polynucleotides and methods of useONCORUS INC·Filed 2018·Application pending·0 cites
- 3242US2017137506A1Treatment of chronic kidney disease and other renal dysfunction using a gdf15 modulatorAVEO PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lorena Lerner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →